A detailed history of Thematics Asset Management transactions in Argenx Se stock. As of the latest transaction made, Thematics Asset Management holds 11,576 shares of ARGX stock, worth $9.25 Million. This represents 0.3% of its overall portfolio holdings.

Number of Shares
11,576
Holding current value
$9.25 Million
% of portfolio
0.3%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 13, 2025

BUY
$532.27 - $656.65 $6.16 Million - $7.6 Million
11,576 New
11,576 $6.38 Million

Others Institutions Holding ARGX

About ARGENX SE


  • Ticker ARGX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,323,800
  • Market Cap $44.2B
  • Description
  • argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...
More about ARGX
Track This Portfolio

Track Thematics Asset Management Portfolio

Follow Thematics Asset Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Thematics Asset Management, based on Form 13F filings with the SEC.

News

Stay updated on Thematics Asset Management with notifications on news.